BackTable Urology
Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo
Dr. Andrea Apolo
And the results just show that adjuvant pembrolizumab is effective in this setting and should be considered an option for patients that have high-risk muscle invasive disease.
0
💬
0
Comments
Log in to comment.
There are no comments yet.